10/11/2018NEJM and CCA Enter Partnership for CVS Research and Training

10/11/2018MEI Pharma and BeiGene Announce Collaboration for ME-401/Zanubrutinib ...

10/11/2018State Council Issues New Document to Reform Licensing Mechanisms

10/10/2018New U.S. Rules on Foreign Investment to Curb Chinese Goldrush in U.S. ...

10/10/2018SMIA Issues Official Notice on Approval of 17 Anticancer Drugs for BMI...

10/9/2018Chinese Prof at MD Anderson Cancer Center under Scrutiny for Spying

10/9/2018Daiichi Sankyo Enters Deal with MVP for Distribution of Pain Medicine ...

10/9/2018China's HIV/AIDS Cases Rise by 14%

10/9/2018China: AstraZeneca’s New Engine for Growth and Innovation

10/9/2018Beigene Teams up With Springworks to Target Advanced Solid Tumors

10/9/2018Listed Chinese Pharma Cos Reports Positive Performance in H1

10/9/2018NHC Reports Higher Health Literacy in China

10/8/2018CDE Solicits Comments on Technical Requirements for Manufacturing Site...

10/8/2018NMPA Issues Rules for Communications Related to Drug R&D and Techn...

10/8/2018Innovent to Start US Trials of Anti-CD47 Cancer Drug

10/8/2018Genscript Denies Fake Data Allegations after Shares Plunge

10/8/2018Biosimilars and Healthcare Policy: What China Can Learn from the EU an...

10/8/2018Yisheng Biopharma Cleared by NMPA to Proceed with PIKA Rabies Vaccine ...

10/8/2018Amyris Enters into Extensive Partnership with Yifan Pharma

10/8/2018Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs

10/8/2018SCMP: Betting Big on Biotech

10/8/2018CANbridge Submits NDA for NERLYNX (neratinib) in China

9/30/2018How Does the Pharma Industry Fit into China's Grand Puzzle of Healthca...

9/30/2018Financial-related Company News in Brief

9/30/2018NMPA Issues Announcement Regarding Direct ADR Reporting by MAHs

9/28/2018Recent Official and Executive Moves

9/28/2018Novartis Enters Deal with CBMG to Make CAR-T Therapy Kymriah

9/27/2018China’s Health Authorities Issue New Rules on Telemedicine

9/27/2018I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics

9/27/2018Alvotech and Changchun HiTech Agree to Codevelop Biosimilars in China

Page:312/779 Total number of articles:23361: [First][<<] [310] [311] [312] [313] [314] [>>] [End]